Preservision AREDS 2

Quick links to important sections

Preservision AREDS 2

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Preservision AREDS 2

Quick Facts

Property Description
Active Ingredients Lutein, Zeaxanthin, Vitamin C, Vitamin E, Zinc, Copper
Form Soft gels or Caplets
Pharmacological Class Ophthalmic Antioxidant and Mineral Combination
Common Use Nutritional support for ocular tissues
Origin Evidence-based AREDS 2 Formula

Identity and Classification: What Type of Formula is PreserVision AREDS 2?

PreserVision AREDS 2 is a specialized Nutritional Supplement classified as an Ophthalmic Antioxidant and Mineral Combination designed for Oral administration. Its unique identity is fundamentally rooted in the AREDS 2 Formula, a specific composition. This Combination product is an Over-the-counter (OTC) preparation manufactured by Bausch + Lomb and is widely recognized for its targeted support of eye health, as opposed to general vitamin products. The formula's composition is aligned with the protocol established for individuals requiring concentrated ocular nutrition.

Composition and Form: What Vitamins, Minerals, and Carotenoids Does it Contain?

The formula's specific composition is defined by the inclusion of the key carotenoids Lutein and Zeaxanthin, along with Ascorbic acid (Vitamin C), dl-alpha tocopheryl acetate (Vitamin E), and the minerals Zinc oxide and Cupric oxide (Copper). This Multivitamin-mineral combination is commonly available in convenient Soft gels or Caplets. The formula represents a significant differentiation from the original AREDS formulation due to the substitution of beta-carotene with Lutein and Zeaxanthin, a change intended to maintain efficacy while enhancing safety for specific patient groups, such as smokers.

General Purpose: What is the Main Benefit of the AREDS 2 Formula?

The general purpose of this specific formulation is to provide concentrated Ocular tissue protection by nutritionally reinforcing the eye’s natural defenses. The components function collectively to deliver potent Ocular Antioxidant Support, aiding in the mitigation of oxidative stress—a biological factor contributing to the age-related degradation of retinal cells. The formula is specifically positioned for adults seeking to support the integrity of the macular structures, which are vital for acute, central vision.

Regulatory References

  1. Age-Related Eye Disease Study 2 (AREDS2) - ClinicalTrials.gov

What side effects are possible with Preservision AREDS 2?

Possible side effects and safety information

The official safety profile for the PreserVision AREDS 2 formula is based on the high-dose concentration of its constituent vitamins (C and E) and minerals (Zinc and Copper), as documented in governmental regulatory sources.

Adverse Reaction Classification

Adverse Reaction Type Classification/Organ Class
Common Adverse Reactions Gastrointestinal Disorders
Serious Systemic Reactions Blood and Lymphatic System Disorders; Immune System Disorders

Common adverse reactions documented in regulatory safety texts are predominantly related to the gastrointestinal system and include stomach upset, nausea, vomiting, or diarrhea. These effects are generally associated with the high mineral content of the formulation.

Serious Safety Considerations

Serious adverse reactions are reported in official documentation, often related to the high mineral dosage. Prolonged, high-dose exposure to zinc, a component of the formula, carries the documented risk of interfering with copper absorption, potentially leading to zinc-induced copper deficiency anemia. Additionally, as with any combination product, rare but serious hypersensitivity reactions are possible, which may include systemic allergic signs.

Population-Specific Safety Patterns

A key safety distinction of the AREDS 2 formula is the exclusion of beta-carotene, which was present in the original formulation. This modification was made following National Eye Institute (NEI) research that documented an association between beta-carotene and an increased risk of lung cancer in current and former smokers. Safety constraints are also noted for individuals with impaired mineral elimination, such as those with renal or hepatic function impairment, or those with pre-existing disorders of copper metabolism.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of this ophthalmic antioxidant and mineral combination is primarily characterized by documented signs of toxicity related to its high-dose components (Zinc, Copper, and Vitamins C and E). Overdose may present with severe gastrointestinal disturbances, including nausea, vomiting, abdominal cramps, and diarrhea. Other systemic manifestations may include headaches and fatigue. Severe over-exposure carries a documented risk of serious systemic outcomes, such as potential organ damage, including liver failure or kidney failure, and acute gastrointestinal bleeding.

A specific risk documented in regulatory sources is severe bleeding (hemorrhage), particularly for individuals concurrently receiving anticoagulant therapy due to high Vitamin E intake.

Required Emergency Actions

Any suspected overdose requires immediate medical attention. Regulatory guidance mandates contacting a poison control center right away. For manifestations classified as severe or life-threatening—such as trouble breathing, loss of consciousness, or convulsions—it is required to contact emergency services (e.g., 911) immediately. Management is based on symptomatic and supportive treatment, as no specific antidote for the combination product is officially documented.

Therapeutic Uses of Preservision AREDS 2

What PreserVision AREDS 2 Treats: Main Uses and Benefits

A primary therapeutic application is the long-term management of intermediate Age-Related Macular Degeneration (AMD), a condition characterized by periods of heightened symptoms. This specialized nutritional support is applied when appropriate after an eye care professional identifies specific high-risk features, such as large drusen, indicating a high potential for the condition to worsen.

The formula is relevant for addressing the risk of advancing to late-stage AMD, which includes the neovascular (wet) form. This formula is commonly used for specific high-risk patient groups, including older adults diagnosed with AMD and former smokers who may assist with support for macular tissue. It is used to manage symptoms associated with age-related macular degeneration, progression risk, and symptoms that interfere with daily functioning.

This formula plays a role in managing the progressive course of the condition and may help support functional stability during episodes of heightened discomfort.


Quick Fact: Support for Macular Health

Property Description
Primary Use Context Long-term chronic management
Targeted Condition Intermediate Age-Related Macular Degeneration
Therapeutic Benefit Support for managing disease progression risk
Relevant Patient Group Older adults with specific high-risk clinical findings

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

Eligibility for using the PreserVision AREDS 2 formula is strictly defined by the clinical criteria established in the Age-Related Eye Disease Study 2 (AREDS2), sponsored by the National Eye Institute (NEI).

Who is Eligible?

The formula is intended only for adults diagnosed with Intermediate Age-Related Macular Degeneration (AMD) in one or both eyes, or Advanced AMD in one eye only. For individuals with a history of smoking (current or former), the AREDS 2 composition is the officially recommended formula, as it is free of beta-carotene, which was contraindicated in the original AREDS formulation for this population.

Who Must Not Use It?

Use is contraindicated for any individual with a known allergy or hypersensitivity to any of the supplement's active or inactive ingredients (Vitamins C and E, Zinc, Copper, Lutein, and Zeaxanthin). The formula is also not recommended for individuals with Early Stage AMD or no AMD, as clinical benefit has not been established for these groups.

Use in the pediatric population is not recommended. For women who are pregnant or breastfeeding, use is classified as requiring professional consultation to assess the benefits and risks of high-dose supplementation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

PreserVision AREDS 2 is a combination nutritional supplement whose interaction profile is defined by the high concentrations of its core components, Zinc and Vitamin E, as documented in government regulatory sources for high-dose vitamins and minerals.

Pharmacodynamic and Absorption Interactions

Interaction Type Interacting Substances/Class Official Regulatory Statement
Pharmacodynamic Potentiation Vitamin K Antagonist Anticoagulants (e.g., Warfarin) The high dose of Vitamin E may potentiate the effect of these medications, which increases the documented risk of bleeding events.
Reduced Drug Exposure Quinolone and Tetracycline Antibiotics The Zinc component forms complexes with these antibiotics in the gastrointestinal tract, inhibiting their absorption and reducing their systemic exposure.

Restrictions and Administration Timing

Administration of PreserVision AREDS 2 must be separated in time from the use of chelation-prone antibiotics and other mineral supplements, such as Iron preparations, typically by two to four hours, to mitigate reduced absorption.

Regulatory documentation also highlights the risk of additive nutritional intake when co-administered with other vitamin-mineral supplements containing high levels of Vitamin C, Vitamin E, or Zinc, which could lead to exceeding officially recognized intake levels. The formula's composition is notable for the exclusion of beta-carotene to prevent a documented, population-specific risk identified in current or former smokers.

Mechanism of Action

The PreserVision AREDS 2 formulation contains a combination of high-dose antioxidants (Vitamins C and E, lutein, zeaxanthin, and copper) and zinc. These components are selectively accumulated in the ocular tissues, particularly the retinal pigment epithelium (RPE) and macula.

Lutein and zeaxanthin are carotenoids that structurally integrate into the macula, forming macular pigment. This pigment acts as a filter for short-wave blue light, reducing photo-oxidative stress on the photoreceptors. They also function as chain-breaking antioxidants, directly quenching reactive oxygen species (ROS) within lipid membranes.

Vitamin C and Vitamin E are non-enzymatic antioxidants. Vitamin C is water-soluble, scavenging free radicals in the aqueous compartments of the cell. Vitamin E is lipid-soluble, protecting the polyunsaturated fatty acids in cell membranes, such as those in photoreceptor outer segments, from lipid peroxidation.

Zinc acts as a cofactor for numerous metalloenzymes, including antioxidant enzymes like superoxide dismutase (SOD), thereby modulating intracellular redox balance. Zinc has also been proposed to influence pathways related to autophagy and gene expression of phagocytosis proteins in the RPE. Copper is included to prevent potential zinc-induced copper deficiency, supporting the function of copper-dependent enzymes. This combined action results in a system-level physiological reduction of oxidative damage and inflammation in the posterior segment of the eye, particularly the macula.

Dosage and Administration Information

Official Administration Guidelines for PreserVision AREDS 2

The usage of the PreserVision AREDS 2 formula follows a specific protocol and is detailed consistently across product labeling.

Administration Scope

Instruction Detail
Route of Administration Oral administration in the form of soft gels, caplets, or chewable tablets.
Dosing Schedule The standard regimen is two units per day. This divided intake delivers the total daily dose of 500 mg Vitamin C, 180 mg Vitamin E, 80 mg Zinc, 2 mg Copper, 10 mg Lutein, and 2 mg Zeaxanthin.
Timing in Relation to Meals Consumption occurs with food or with a meal. This condition supports the absorption of the formula's fat-soluble components, such as Vitamin E and the carotenoids.
Special Procedural Conditions The formulation is beta-carotene free, a deliberate compositional principle intended for individuals who are current or former smokers, a population that may be restricted from using the original AREDS formula.
Preparation Requirement For the chewable tablet form, directions specify that the unit must be chewed and not swallowed whole.

Resulting Procedural Structure

The established usage pattern is a long-term chronic nutritional strategy. The procedural steps involve taking one unit in the morning with a meal and the second unit in the evening with a meal, ensuring consistent daily nutrient delivery. The inclusion of Copper is integral to the administration of high-dose Zinc, serving as a mechanism to maintain the overall balance of essential minerals.

Recent Clinical Evidence

Preservision AREDS 2: Recent Clinical Evidence

The formulation known as AREDS 2, which includes Lutein and Zeaxanthin in place of Beta-Carotene, is based on a major clinical trial sponsored by the U.S. National Eye Institute (NEI). The primary goal of the Age-Related Eye Disease Study 2 (AREDS2) was to assess whether adding Lutein, Zeaxanthin, and/or Omega-3 fatty acids to the original AREDS formula would further reduce the risk of progression to advanced Age-Related Macular Degeneration (AMD).


Key Findings of the AREDS2 Trial

The trial included over 4,200 participants with intermediate AMD, or advanced AMD in one eye, and tracked their condition over five years. The key findings related to the updated nutrient formula were:

  • Formula Modification: The substitution of Lutein (10 mg) and Zeaxanthin (2 mg) for Beta-Carotene was found to be an appropriate modification. This change maintained the protective benefit against progression to advanced AMD while eliminating the elevated risk of lung cancer observed in the original formula among former smokers.
  • Omega-3 Fatty Acids: Adding Omega-3 fatty acids (DHA/EPA) to the AREDS formula did not demonstrate an overall beneficial effect on the progression of AMD.
  • Long-Term Benefit: A 10-year follow-up of the AREDS2 participants reaffirmed the benefit of the updated formulation, showing sustained reduction in the risk of progression to late-stage AMD.

Formula Composition

Based on these findings, the recommended AREDS2 supplement formula contains a specific combination and dosage of vitamins and minerals. The formula provides the following daily amounts:

Nutrient Daily Amount (mg/IU)
Vitamin C 500 mg
Vitamin E 400 IU
Lutein 10 mg
Zeaxanthin 2 mg
Zinc 80 mg
Copper 2 mg

Key Studies & References Long-term Effects of Lutein/Zeaxanthin and Omega-3 Fatty Acids on Age-Related Macular Degeneration: The AREDS2 10-Year Follow-up Report

Frequently Asked Questions (FAQ)

Common questions about Preservision AREDS 2 (FAQ)


Q: What is the recommended age range for people taking Preservision AREDS 2?

The formula’s use is strictly defined by the clinical trial criteria, which focused on adults who are generally 50 years of age or older and who have been diagnosed with a specific stage of age-related macular degeneration (AMD). The use of this formula is not recommended for the pediatric population, which includes children and teenagers.


Q: Is this supplement meant to prevent eye conditions, or only slow their progression?

Clinical studies indicate the AREDS 2 formula helps to reduce the risk of progression to advanced age-related macular degeneration (AMD) in people who already have intermediate or advanced AMD in one eye. Clinical benefit has not been established for the purpose of preventing the condition in individuals with early or no AMD.


Q: Does Preservision AREDS 2 contain any ingredients derived from common allergens like shellfish or gluten?

Official product information states that certain forms of the supplement are labeled as free from common additives like gluten and soy derivatives. However, the presence of specific potential allergens may vary based on the exact product and formulation. Reviewing the complete ingredient list on the specific product packaging is recommended for full details.


Q: Can taking too much Preservision AREDS 2 be harmful?

Taking more than the recommended daily dose may increase the risk of documented serious adverse effects, primarily zinc-induced copper deficiency. It may also lead to consumers surpassing official safe upper intake levels for various components.


Q: Are there different concentrations or strengths of Preservision AREDS 2?

The AREDS 2 formula, based on the clinical study, uses a fixed concentration of active ingredients (Lutein, Zeaxanthin, Vitamins C and E, Zinc, and Copper) that is consistent across all PreserVision forms, including Caplets, MiniGels, and Chewables. While different forms are available, they are designed to deliver the same precise daily dose.


Q: Why are there different versions like 'Preservision AREDS 2 MiniGels'?

Different versions are available to address consumer needs related to specific absorption profiles or swallowing difficulty. For example, MiniGels are designed with an enhanced formulation for the absorption of Lutein and Zeaxanthin.


Q: How long does it usually take before a person notices any effects from taking Preservision AREDS 2?

The AREDS 2 formula is defined as a long-term chronic nutritional strategy aimed at protecting the integrity of ocular tissues over time. The clinical trial that established its benefit tracked progression over five years. As such, the effects are not expected to be immediately noticeable.


Q: Is the full benefit of Preservision AREDS 2 achieved after a certain number of months?

The formula is intended for consistent daily intake over a long period to maintain protective nutrient levels in the eye. The AREDS 2 study that established its benefit tracked participants over a duration of five years. Achieving the full protective benefit is generally tied to consistent, long-term use.


Q: Does the formula expire, and does potency decrease over time?

Official regulatory guidance requires that unused or expired medications and supplements be disposed of safely. The product packaging includes an expiration date which signifies the time period during which the formula is expected to remain at its full intended potency.


Q: Are the side effects generally mild, or are severe reactions common?

Official safety data classifies documented adverse reactions into two types: Common reactions, which are typically mild (like gastrointestinal upset), and Serious systemic reactions (like zinc-induced copper deficiency anemia). The risk of serious reactions is documented in regulatory texts but is generally considered rare compared to the common, milder effects.


Q: What should I do if I experience nausea after taking the capsules?

Nausea and stomach upset are classified as commonly documented side effects, generally associated with the high mineral content of the formula. If any side effects, including nausea, persist or are concerning, individuals should refer to the full safety information and regulatory guidance on adverse events.


Q: Does Preservision AREDS 2 contain Vitamin E, and is there a limit to how much Vitamin E is safe?

The formula contains a high dose of Vitamin E (400 IU daily). Regulatory documentation highlights the risk of interaction with certain medications, such as blood thinners, due to this high level. Consumers should be aware of official upper intake limits for Vitamin E when taking this supplement.


Q: Can it be taken alongside supplements like Omega-3 fish oil?

The AREDS2 clinical trial included a group that took Omega-3 fatty acids alongside the core AREDS 2 formula. The study found that adding Omega-3s did not demonstrate an overall beneficial effect on the progression of AMD in the participants.


Q: Has the AREDS 2 study been replicated by other research groups?

The efficacy of the AREDS 2 formula was established in the original five-year clinical trial sponsored by the NIH. The benefits have been reaffirmed by subsequent follow-up studies conducted by the National Eye Institute over a 10-year period.


Q: How does the dosage of Zinc in Preservision AREDS 2 compare to a typical daily zinc supplement?

The daily dose of 80 mg of Zinc in the PreserVision AREDS 2 formula is notably higher than the standard Recommended Dietary Allowance (RDA) for zinc, which is typically 8 mg to 11 mg per day for adults. This high concentration is part of the specific AREDS 2 protocol.


Q: Is there a different Preservision product available for people who are non-smokers?

The PreserVision AREDS 2 formula is beta-carotene free and is appropriate for all users, including non-smokers. However, the manufacturer also offers products with different component combinations, such as those that include a multivitamin or the original AREDS formula, though the latter is not recommended for smokers.


Q: Does the lutein in the formula come from marigolds or another source?

According to official product information and ingredient lists, the lutein and zeaxanthin in the PreserVision AREDS 2 formula are typically derived from marigold flower and/or paprika fruit extract.


Q: Do I need to inform my dentist that I am taking Preservision AREDS 2?

Official regulatory guidance highlights the importance of providing an up-to-date list of all medications and supplements to any healthcare professional, including dentists. This is because the high-dose components, such as Vitamin E, may pose interaction risks with certain medical treatments or procedures.


Q: Can this supplement change the results of my eye exam?

The components lutein and zeaxanthin structurally integrate into the eye and are known to increase macular pigment density. This density is sometimes measured during specialized eye exams; the supplement is designed to support the ocular tissue in patients undergoing regular eye examinations.


Q: Can taking this supplement affect liver enzyme levels?

Safety constraints note that caution is needed for individuals with pre-existing hepatic (liver) function impairment. However, no general effect on liver enzyme levels is listed as a common or serious adverse reaction in official product labeling.


Q: Are there any documented cases of overdose with Preservision AREDS 2?

Regulatory documentation contains information on the signs of overdose, which typically include severe stomach upset or vomiting. Additionally, overdose with products containing iron (found in some combination products) is highlighted as a serious risk.


Q: Does the FDA approve or regulate supplements like Preservision AREDS 2?

The product is classified as a dietary supplement and is therefore regulated by the FDA under the Dietary Supplement Health and Education Act (DSHEA). This means that statements regarding its purpose have not been evaluated by the FDA, and it is not subject to the same approval process as prescription drugs.


Q: Are there different quality standards for the ingredients used in various brands of AREDS 2 supplements?

As a dietary supplement, this product is regulated by the FDA under the Dietary Supplement Health and Education Act (DSHEA). This act sets specific standards for the manufacturing, safety, and labeling of supplements, though it does not involve the same pre-market approval process as prescription drugs.


Q: Can I crush the capsules if I have trouble swallowing them?

Official administration guidelines specify that the chewable tablet form must be chewed and not swallowed whole. Instructions for altering the soft gel or caplet forms (such as crushing) are not present in the regulatory text. Different product forms, such as MiniGels or chewable tablets, are available to address potential swallowing difficulties.


Q: What are the alternatives for someone who cannot tolerate the zinc content in the formula?

While the full AREDS 2 formula is the standard, alternatives that contain the other core components without zinc and copper are commercially available. These alternatives are designed for individuals with zinc sensitivity or those with specific recommendations from a healthcare professional.

How should Preservision AREDS 2 be stored and disposed of?

Official Storage and Disposal Requirements

PreserVision AREDS 2 soft gels must be stored under specific conditions to maintain product integrity, as defined by regulatory labeling.

Storage Conditions

Requirement Official Instruction
Temperature Store at Controlled Room Temperature, between 15 C and 25 C (59 F and 77 F). Do not exceed 30 C (86 F).
Protection Keep in a dry place and protect from direct sunlight and excessive heat.
Packaging Keep the cap tightly closed; do not use the product if the seal is broken.

Handling and Disposal

The product must be stored out of the sight and reach of children, as required for safety. Disposal of expired or unused soft gels must be performed according to local, regional, and national regulations. The product should not be flushed down a toilet or poured into a drain unless specific guidance permits it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Preservision AREDS 2 found in:

A-Z Index: